NXP Semiconductors (NXPI) Guides 4Q Down vs. Flat Consensus; Mizuho Securities Reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Sterne Agee CRT: NXP (NXPI) is a Buying Opportunity, Pullback Shortlived
October 30, 2015 7:27 AM EDTDouglas Freedman from Sterne Agee CRT published a note describing why the NXP (NASDAQ: NXPI) weakness is overblown. The analyst believes that accounting practices and a reliance on China rather than a fundamental break in the business model are to blame.
Management attributed the Q4 revenue outlook of mid-teens percentage sequential decline to a large-scale inventory adjustment at channel... More
NXP Semiconductors (NXPI) Hit by Late 3Q Demand Weakness; Susquehanna Cuts Price Target to $100
October 29, 2015 3:21 PM EDTSusquehanna maintained a Positive rating on NXP Semiconductors NV (NASDAQ: NXPI), and cut the price target to $100.00 (from $128.00), following the company's 3Q Results. NXPI reported revenue of $1.522 bln, in-line with the lower end of guidance ($1.52 bln-$1.575 bln), but below consensus of $1.552 bln. EPS of $1.57 was well ahead of consensus of $1.50.
Analyst Chris Caso... More
Decline in Secure Interfaces and Power Business Hits NXP Semiconductors' (NXPI) Revenue; Needham & Company Cuts Price Target to $100
October 29, 2015 3:14 PM EDTNeedham & Company maintained a Strong Buy rating on NXP Semiconductors NV (NASDAQ: NXPI), and cut the price target to $100.00 (from $140.00), following the company's 3Q15 earnings report. Revenue of $1.52Bn was slightly below our in-line $1.55Bn estimate, largely due to a decline in the Secure Interfaces and... More
Streetinsider.com's Hot Lunchtime Reads 10/29: (FNFG) (ABX) (FFF) (ANTM)
October 29, 2015 12:17 PM EDTThe following is a list of notable articles to help get you through the lunch hour:Inventory Correction Led to NXP Semiconductors (NXPI) Guide Down ->... More
Inventory Correction Led to NXP Semiconductors (NXPI) Guide Down
October 29, 2015 11:10 AM EDTNXP Semiconductors (NASDAQ: NXPI) is getting taken to the woodshed today after reporting ho-hum third quarter results but more importantly lowering fourth guidance.
NXPI reported Q3 EPS of $1.57, $0.07 better than the analyst estimate of $1.50. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.55 billion. For... More
NXP Semiconductors (NXPI) Guide Down More Aggressive Than End Demand Trends - Mizuho
October 29, 2015 10:16 AM EDTNXP Semiconductors (NASDAQ: NXPI) 15% reduction in 4Q15 guidance is to correct some of the inventories that built up in the past quarter. Ex-inventory alignment, guidance would have only been down low to mid-single digits. NXPI does not think it has lost any market share or key... More
Pre-Open Stock Movers 10/29: (LOCK) (HBI) (AGN) Higher; (STRP) (AFOP) (NXPI) Lower (more...)
October 29, 2015 9:32 AM EDTRevance Therapeutics (Nasdaq: RVNC) 40.3% HIGHER; announced positive 24-week results today from its multi-center BELMONT Phase 2 active comparator study of injectable RT002. The ongoing study for the treatment of glabellar lines in 268 subjects compared the safety,... More
Wall St. slips on tech results, chances of Fed hike
October 29, 2015 7:22 AM EDTBy Lewis Krauskopf
(Reuters) - U.S. stocks ended slightly lower on Thursday as the market digested disappointing tech earnings reports and the potential for an interest rate hike in December.
The Federal Reserve, which kept rates unchanged at its policy meeting that ended Wednesday, downplayed concerns about global growth and indicated confidence in the U.S. job market's recovery.
Stocks had jumped on Wednesday following the Fed statement and, after a strong run from the end of September, were due for a "reprieve," said Jason Ware, chief investment officer at Albion Financial, in Salt Lake... More
NXP Semiconductors (NXPI) Tops Q3 EPS by 7c; Sees Q4 Revs Down Low to Upper-Teens
October 29, 2015 6:38 AM EDTAfter the close, NXP Semiconductors (NASDAQ: NXPI) reported Q3 EPS of $1.57, $0.07 better than the analyst estimate of $1.50. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.55 billion.
Sees Q4 revenue down in the low to upper-teens range.
Our profitability in the third quarter of 2015 was very strong, as NXP delivered total revenue of $1.52 billion and non-GAAP operating margin of nearly 30 percent. Revenue was approximately flat versus the same period in the prior year, and... More
NXP Semiconductors (NXPI), Sequent Announce Collaboration to Bring Cards to Mobile
October 28, 2015 1:02 PM EDTNXP Semiconductors N.V. (NASDAQ: NXPI), the leader in Near Field Communication (NFC) solutions and Sequent Software, the platform bringing cards to mobile, have announced a collaboration to increase the use of mobile devices in transit, access control and hospitality applications. Sequent has licensed NXPs MIFARE DESFire and MIFARE4Mobile V1.01 and integrated them into the Sequent Platform, allowing consumers to access potentially millions of credentials for use in real-world environments with their mobile devices.
Our new... More
Pre-Open Stock Movers 10/28: (CMI) (HOT) (CAB) (AIG) (AAPL) Higher; (MCUR) (AKAM) (ICPT) Lower (more...)
October 28, 2015 9:31 AM EDTMacrocure Ltd. (NASDAQ: MCUR) 63.8% LOWER; announced that results from a pivotal Phase 3 multicenter, randomized, double-blind, parallel-group, sham-controlled study (MC-102) of CureXcell® in the treatment of diabetic foot ulcers (DFUs) did not meet its primary endpoint. CureXcell, the Company's lead product candidate, did not show a statistically significant proportion of subjects with complete closure at 16 weeks and sustained complete closure for four additional weeks. In addition, CureXcell did not meet the secondary endpoints of the study.
Vocera Communications (NYSE:... More
After-Hours Movers 10/27: (VCRA) (NOC) (CRUS) Higher; (AKAM) (TWTR) (RAD) Lower (more...)
October 27, 2015 6:26 PM EDTVocera Communications (NYSE: VCRA) 25.5% HIGHER; reported Q3 EPS of ($0.04), $0.05 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $24.96 million.
Akamai Technologies (NASDAQ: AKAM) 14% LOWER; reported Q3 EPS of $0.62, $0.04 better than the analyst estimate of $0.58. Revenue for the quarter came in at $551 million versus the consensus estimate of $550.29 million. Provides weak outlook.
Robust iPhone sales boost Apple's chip suppliers
October 27, 2015 5:59 PM EDTSAN FRANCISCO (Reuters) - Shares of companies that sell semiconductors to Apple Inc (NASDAQ: AAPL) got a shot in the arm on Tuesday after the iPhone maker posted a fiscal fourth-quarter report that pleased Wall Street.
Supplying technology to Apple can turn small companies into Wall Street darlings as new versions of the iPhone break quarterly sales records and remain the gold... More

